# A Study to Assess the Bioequivalence of Darunavir When Co-Administrated With Cobicistat Under Fed and Fasted Conditions

> **NCT01619527** · PHASE1 · COMPLETED · sponsor: **Janssen R&D Ireland** · enrollment: 133 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** darunavir
- **DRUG:** cobicistat

## Key facts

- **NCT ID:** NCT01619527
- **Lead sponsor:** Janssen R&D Ireland
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 133 (ACTUAL)
- **Last updated:** 2013-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01619527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01619527, "A Study to Assess the Bioequivalence of Darunavir When Co-Administrated With Cobicistat Under Fed and Fasted Conditions". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01619527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*